NEVRO CORP's ticker is and the CUSIP is 64157FAC7. A total of 16 filers reported holding NEVRO CORP in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $933 | +1.0% | 0 | – | 0.00% | 0.0% |
| Q2 2023 | $924 | -1.7% | 0 | – | 0.00% | 0.0% |
| Q1 2023 | $940 | +2.5% | 0 | – | 0.00% | 0.0% |
| Q4 2022 | $917 | -99.9% | 0 | – | 0.00% | 0.0% |
| Q3 2022 | $946,000 | +1.6% | 0 | – | 0.00% | 0.0% |
| Q2 2022 | $931,000 | -92.8% | 0 | -100.0% | 0.00% | -93.3% |
| Q1 2022 | $12,972,000 | -2.9% | 12,000,000 | 0.0% | 0.02% | +7.1% |
| Q4 2021 | $13,355,000 | -50.6% | 12,000,000 | -40.0% | 0.01% | -53.3% |
| Q3 2021 | $27,012,000 | +29.9% | 20,000,000 | +66.7% | 0.03% | +30.4% |
| Q2 2021 | $20,790,000 | -3.7% | 12,000,000 | -14.3% | 0.02% | -11.5% |
| Q1 2021 | $21,586,000 | -2.5% | 14,000,000 | +15.3% | 0.03% | -7.1% |
| Q4 2020 | $22,143,000 | +48.1% | 12,146,000 | +25.9% | 0.03% | +33.3% |
| Q3 2020 | $14,954,000 | +43.1% | 9,646,000 | +26.2% | 0.02% | +31.2% |
| Q2 2020 | $10,447,000 | – | 7,646,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 61,000,000 | $65,368,000 | 1.46% |
| WOLVERINE ASSET MANAGEMENT LLC | 50,366,000 | $53,863,000 | 0.53% |
| DeepCurrents Investment Group LLC | 12,930,000 | $13,857,000 | 0.43% |
| Aequim Alternative Investments LP | 7,300,000 | $7,891,000 | 0.21% |
| ADVENT CAPITAL MANAGEMENT /DE/ | 5,290,000 | $5,656,000 | 0.09% |
| CAPSTONE INVESTMENT ADVISORS, LLC | 30,167,000 | $32,611,000 | 0.09% |
| Verition Fund Management LLC | 3,823,000 | $4,133,000 | 0.05% |
| PALISADE CAPITAL MANAGEMENT, LP | 1,534,000 | $1,643,000 | 0.04% |
| LAZARD ASSET MANAGEMENT LLC | 12,000,000 | $12,972,000 | 0.02% |
| Rock Springs Capital Management LP | 500,000 | $541,000 | 0.01% |